Organoid-on-chip technology merges patient-derived organoids with microfluidic engineering to recreate human physiology and ...
Pakistan’s 2025 mobile manufacturing sees sharp growth for Vivo and Tecno as consumers shift toward mid-range smartphones.
As AI agents take charge of discovery, comparison, and purchase, India’s marketing playbook shifts from chasing clicks to ...
No changes in protocol recommended for LUGANO and LUCIA clinical trials –– Masked safety data continues to show no safety signals, consistent ...
Ellucian, the leading higher education technology solutions provider, today announced that RAK Medical & Health Sciences ...
Supercomputing 2025 ? Hammerspace, the high-performance data platform for AI Anywhere, today announced the upcoming release of Hammerspace v5.2, delivering performance, security and ecosystem ...
SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing ...
Earlier this month, CRISPR Therapeutics announced positive Phase 1 data for its investigational in vivo CRISPR/Cas9 therapy CTX310, which showed substantial and durable reductions in key lipid levels ...
Without more capital, Europe’s scientific leadership will not translate into industrial strength, warns Jérôme Van Biervliet ...
Jefferies London Healthcare Conference 2025 November 18, 2025 9:00 AM ESTCompany ParticipantsMaxwell Krakowiak - Senior VP ...
Q3 2025 Earnings Call Transcript November 13, 2025 Omeros Corporation beats earnings expectations. Reported EPS is $-0.19, ...
SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback